These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10971132)

  • 1. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon.
    Hijikata M; Ohta Y; Mishiro S
    Intervirology; 2000; 43(2):124-7. PubMed ID: 10971132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
    Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
    J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection.
    Suzuki F; Arase Y; Suzuki Y; Tsubota A; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Satoh J; Kumada H
    J Viral Hepat; 2004 May; 11(3):271-6. PubMed ID: 15117331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.
    Shaker OG; Abdel-Rahim MT; Bayoumi ST
    Cell Biochem Biophys; 2015 Mar; 71(2):617-25. PubMed ID: 25239021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients.
    Bader El Din NG; Salum GM; Anany MA; Ibrahim MK; Dawood RM; Zayed N; El Abd YS; El-Shenawy R; El Awady MK
    J Interferon Cytokine Res; 2015 Aug; 35(8):641-8. PubMed ID: 25868067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro.
    Hijikata M; Mishiro S; Miyamoto C; Furuichi Y; Hashimoto M; Ohta Y
    Intervirology; 2001; 44(6):379-82. PubMed ID: 11805446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between single nucleotide polymorphisms in -88 and -123 loci of MxA gene promoter region and HCV susceptibility and IFN-α efficacy].
    Hu CH; Chen J; Yang R; Li NN; Yang B; Ma D; Liang XC; Wang Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1307-10. PubMed ID: 23232524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic polymorphisms of MxA protein and eIF-2a-reg2 and their responses to interferon treatment in patients with chronic hepatitis B].
    Huang YX; Ma LN; Chen XY; Li Z; Huang YL; Shen CL; Ma B
    Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):187-91. PubMed ID: 17407708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential transcriptional expresión of the polymorphic myxovirus resistance protein A in response to interferon-alpha treatment.
    Fernández-Arcás N; Blanco A; Gaitán MJ; Nyqvist M; Alonso A; Reyes-Engel A
    Pharmacogenetics; 2004 Mar; 14(3):189-93. PubMed ID: 15167707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
    Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proximal interferon-stimulated response elements are essential for interferon responsiveness: a promoter analysis of the antiviral MxA gene.
    Ronni T; Matikainen S; Lehtonen A; Palvimo J; Dellis J; Van Eylen F; Goetschy JF; Horisberger M; Content J; Julkunen I
    J Interferon Cytokine Res; 1998 Sep; 18(9):773-81. PubMed ID: 9781817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interferon gamma and tumor necrosis factor-related apoptosis-inducing ligand receptor 1 single nucleotide polymorphism in natural clearance and treatment response of HCV infection.
    Azam S; Manzoor S; Imran M; Ashraf J; Ashraf S; Resham S; Ghani E
    Viral Immunol; 2015 May; 28(4):222-8. PubMed ID: 25798684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy.
    Antonelli G; Simeoni E; Turriziani O; Tesoro R; Redaelli A; Roffi L; Antonelli L; Pistello M; Dianzani F
    J Interferon Cytokine Res; 1999 Mar; 19(3):243-51. PubMed ID: 10213463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the Relation Between SNP in MxA Gene and the Responsiveness of Egyptian HCV Genotype 4 Patients to Pegylated Interferon and Ribavirin Treatment.
    Hassany M; Gamal A; Zaki N; Eysa B
    Gastroenterology Res; 2017 Apr; 10(2):100-105. PubMed ID: 28496530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis.
    Torisu H; Kusuhara K; Kira R; Bassuny WM; Sakai Y; Sanefuji M; Takemoto M; Hara T
    Neurology; 2004 Feb; 62(3):457-60. PubMed ID: 14872030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.
    Kong XF; Zhang XX; Gong QM; Gao J; Zhang SY; Wang L; Xu J; Han Y; Jin GD; Jiang JH; Zhang DH; Lu ZM
    J Interferon Cytokine Res; 2007 Sep; 27(9):809-18. PubMed ID: 17892402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.
    Knapp S; Yee LJ; Frodsham AJ; Hennig BJ; Hellier S; Zhang L; Wright M; Chiaramonte M; Graves M; Thomas HC; Hill AV; Thursz MR
    Genes Immun; 2003 Sep; 4(6):411-9. PubMed ID: 12944978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients.
    Shaker O; Ahmed A; Doss W; Abdel-Hamid M
    J Viral Hepat; 2010 Nov; 17(11):794-9. PubMed ID: 20002306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter structure of the MxA gene that confers resistance to influenza virus.
    Nakade K; Handa H; Nagata K
    FEBS Lett; 1997 Dec; 418(3):315-8. PubMed ID: 9428735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin.
    Sadeq R; Mohtady H; Al Badawy N; Ibrahim S; Omar AR; Husseiny MI; El Zowalaty M
    J Infect Dev Ctries; 2013 Nov; 7(11):859-67. PubMed ID: 24240045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.